Company · founded 2000
OncoGenex Pharmaceuticals (United States)
Bothell, United States · oncogenex.com
- Citations, last 5 years
- 155
- Works, last 5 years
- 13
- h-index
- 21
- Scientists listed
- 0
- Grants since 2016
- 3
Grants received
2021–2024 · research · R44
Benefit and Safety of Cytisinicline (cytisine) for Cessation of Nicotine E-cigarette Use
Cindy Jacobs · OncoGenex Pharmaceuticals (United States) · funded by National Institutes of Health
2021–2022 · research · R42
Benefit and Safety of Cytisinicline (cytisine) for Cessation of Nicotine E-cigarette Use
Cindy Jacobs · OncoGenex Pharmaceuticals (United States) · funded by National Institutes of Health
2021–2024 · research · R44
Benefit and Safety of Cytisinicline (cytisine) for Cessation of Nicotine E-cigarette Use
Cindy Jacobs · OncoGenex Pharmaceuticals (United States) · funded by National Institutes of Health